Log in to search using one of your social media accounts:

 

Cannabis marketplace scores venture capital from Nosara, Lerer Hippeau and others
Now that the New York State Department of Health has warmed up to medical marijuana and expanded the state's provisions regarding distribution, investors are approaching the cannabis industry with more fervor than ever before. Look at LeafLink, a two-year-old marketplace for wholesale cannabis. The New York-based company raised one of the largest funding rounds in the cannabis tech space to date. Nosara Capital, a London-based venture capital shop, led a $10 million Series A effort with investment… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 21, 2017 Category: American Health Authors: Anthony Noto Source Type: news

RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development
NEW YORK and TEL AVIV, Israel, Nov. 16, 2017 -- (Healthcare Sales & Marketing Network) -- RDD Pharma, a leader in developing treatments for lower gastro-intestinal disorders, has raised $9.5M in Series B funding, including $6M from two new investors, Phar... Biopharmaceuticals, Gastroenterology, Venture Capital RDD Pharma, anal fissure, fecal incontinence, colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 16, 2017 Category: Pharmaceuticals Source Type: news

Arterys Completes Series B to Accelerate Product Commercialization
Imaging analytics leader closes $30M round led by Temasek, along with Varian, Northwell Health Ventures, NewYork-Presbyterian, GE Ventures and several leading venture investors SAN FRANCISCO, Nov. 15, 2017 -- (Healthcare Sales & Marketing Network) -- A... Devices, Radiology, Venture Capital Arterys, imaging analytics, medical image analytics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2017 Category: Pharmaceuticals Source Type: news

Outpost Medicine Appoints Scott Byrd as Chief Executive Officer and Raises $20 Million in Series A Financing Extension
New Investor Takeda Ventures Joins Syndicate; Proceeds to Fund Lead Clinical Stage Program for the Treatment of Overactive Bladder and Irritable Bowel Syndrome INDIANAPOLIS and LONDON, Nov. 15, 2017 -- (Healthcare Sales & Marketing Network) -- Outpost ... Biopharmaceuticals, Venture Capital, Personnel Outpost Medicine, Irritable Bowel Syndrome, Overactive Bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2017 Category: Pharmaceuticals Source Type: news

Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs
The largest investment round for a private medical device company in Europe in 2017 EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 -- (Healthcare Sales & Marketing Network) -- Xeltis, a clinical-stage medical device company pioneering a resto... Devices, Cardioloy, Venture Capital Xeltis , Endogenous Tissue Restoration, heart valve therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2017 Category: Pharmaceuticals Source Type: news

Houston medical software co. reveals raise, expansion plans
The round was co-led by Zurich-based Redalpine Venture Capital and Boston-based First Star Venture Capital along with Slovenian firm Pikas d.o.o. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Jack Witthaus Source Type: news

How Locus landed $19M from ARTIS, Tencent
Morrisville-based Locus Biosciences – which spun out of N.C. State University and formed in 2015 – has secured $19 million in Series A funding. The round was led by San Francisco-based venture capital firm ARTIS Ventures and also included Chinese technology giant Tencent Holdings Limited, Abstract Ventures, and the North Carolina Biotechnology Center among other investors.  “The big thing you can count on from Stuart Peterson (president of ARTIS) is he is going to be investing in real disruption,”… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Jennifer Henderson Source Type: news

Bill Gates Makes $100 Mln Personal Investment to Fight Alzheimer's Bill Gates Makes $100 Mln Personal Investment to Fight Alzheimer's
Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Bill Gates makes $100 million personal investment to fight Alzheimer's
LONDON, Nov 13 (Reuters) - Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease. (Source: Reuters: Health)
Source: Reuters: Health - November 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Microsoft founder Gates commits $100 million for fund, start-ups, to fight Alzheimer's
LONDON (Reuters) - Billionaire Microsoft co-founder Bill Gates is to invest $50 million in the Dementia Discovery Fund, a venture capital fund that brings together industry and government to seek treatments for the brain-wasting disease. (Source: Reuters: Health)
Source: Reuters: Health - November 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Outcome Health sued by major investors
Outcome Health investors sued the company on Tuesday, charging that the startup committed fraud in order to raise almost $500 million earlier this year. Units of Goldman Sachs (NYSE: GS), Alphabet (Nasdaq: GOOGL) and Pritzker Group Venture Capital, among others, filed a lawsuit in New York state court against Outcome, company CEO Rishi Shah and current President Shradha Agarwal, according to the Chicago Tribune.  Chicago-based Outcome installs v ideo screens at medical offices and pharmaceutical… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 8, 2017 Category: Pharmaceuticals Authors: Gina Hall Source Type: news

Genisphere Raises $7 Million to Advance 3DNA(R) Drug Delivery System
HATFIELD, Pa., Nov. 1, 2017 -- (Healthcare Sales & Marketing Network) -- Genisphere LLC announced it has completed a $7 million capital raise to advance its 3DNA® nanotechnology platform for targeted drug delivery and to serve other corporate purposes... Biopharmaceuticals, Oncology, Drug Delivery, Venture Capital Genisphere, 3DNA, targeted drug delivery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 1, 2017 Category: Pharmaceuticals Source Type: news

Venture capital and the future of dermatology: A reassessment
Dr. Norman Levine offers bits of advice for those considering this type of change in your practice for those considering selling their practices to venture capital-backed enterprises based on his experience with one such company. (Source: Dermatology Times)
Source: Dermatology Times - November 1, 2017 Category: Dermatology Source Type: news

LumiThera Closes Series B Round of Financing
SEATTLE, Oct. 31, 2017 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a clinical stage private medical device company creating a non-invasive photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has comple... Devices, Ophthalmology, Venture Capital, Personnel LumiThera, photobiomodulation, Age-related Macular Degeneration, dry AMD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 31, 2017 Category: Pharmaceuticals Source Type: news

VitalConnect Raises $38 Million in a Series C Equity Financing Round
Company created lightest, real-time, FDA Class 2 wearable biosensor for healthcare SAN JOSE, Calif., Oct. 31, 2017 -- (Healthcare Sales & Marketing Network) -- VitalConnect, Inc., a leader in wearable biosensor technology for wireless monitoring in hos... Devices, Monitoring, Venture Capital VitalConnect, VitalPatch (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 31, 2017 Category: Pharmaceuticals Source Type: news

Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies
Company pioneers a novel integrated drug discovery platform to advance targeted protein degradation CAMBRIDGE, Mass., Oct. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Kymera Therapeutics LLC today announced a $30M Series A Financing round to ... Biopharmaceuticals, Venture Capital, Personnel Kymera Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 30, 2017 Category: Pharmaceuticals Source Type: news

HighLife Medical raises $14m for transcatheter mitral valve replacement
HighLife Medical said today that it raised more than $14 million for the replacement heart valve it’s developing to treat mitral regurgitation. Paris- and Irvine, Calif.-based HighLife said the €12.3 million round was led by European venture capital shop Soffinova Partners, joined by prior backers LivaNova (NSDQ:LIVN) and HighLife founder & CEO Georg Börtlein – who also co-founded CoreValve, the aortic valve replacement company acquired in 2009 by Medtronic (NYSE:MDT) for $700 million. HighLife’s transcatheter mitral valve replacement uses a ring around the diseased valve&rsqu...
Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Replacement Heart Valves Wall Street Beat HighLife Source Type: news

Spinal Singularity Closes Seed Funding Round for $3.1M
SAN CLEMENTE, Calif., Oct. 19, 2017 -- (Healthcare Sales & Marketing Network) -- Derek Herrera, the founder of Spinal Singularity, announced the closing of an equity investment in the amount of $3.1M. The round was led by Baker & Eastlack Ventures and in... Devices, Urology, Venture Capital Spinal Singularity, Connected Catheter, Lower Urinary Tract Dysfunction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 19, 2017 Category: Pharmaceuticals Source Type: news

Mass. biotechs flush with cash as VC dollars pour in
Life sciences firms based in the state raised more than $3 billion in venture capital investments in 2016, according to a report this week by trade group MassBio. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 18, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

An Unusual Business Model
In the wide field of incubators, accelerators, co-working and wet lab spaces, and venture capital, Naglreiter Medical Device Development Organization (NMDDO) occupies a unique niche. The company, based in Miramar, FL, was started with the goal of reducing the time and resources that go into building a new medical device company or developing an innovative medical technology. Weeks or months, as well as millions of dollars can go into finding or building a facility, crafting a quality system, and hiring talent. NMDDO offers entrepreneurs a chance to skip to the fun stuff—developing the technology or product. The compa...
Source: MDDI - October 17, 2017 Category: Medical Devices Authors: Marie Thibault Tags: Medical Device Business Source Type: news

Illumina Ventures Closes $230 Million Fund
Genomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health SAN FRANCISCO, Oct. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Illumi... Biopharmaceuticals, Personalized Medicine, Venture Capital Illumina Ventures, genomics, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 16, 2017 Category: Pharmaceuticals Source Type: news

University spin-outs announced as winners of major venture capital initiative
Two University of Bristol spin-out companies, Zeetta Networks and KETS Quantum Security, have been announced as winners of a major venture capital initiative led by BT, the Telecom Infra Project (TIP) and Facebook, which will provide them with access to investors with funds totalling £ 125 million. (Source: University of Bristol news)
Source: University of Bristol news - October 16, 2017 Category: Universities & Medical Training Tags: Research, International, Business and Enterprise; Faculty of Engineering, Faculty of Engineering, School of Computer Science, Electrical and Electronic Engineering, and Engineering Maths; Press Release Source Type: news

Spruce Biosciences Provides Corporate Update on Series A Venture Financing, Leadership Team and Lead Clinical Program
Clinical-stage, rare endocrine disease Company expands leadership team and advances lead candidate for congenital adrenal hyperplasia SAN FRANCISCO, Oct. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Spruce Biosciences, a clinical-stage biotech... Biopharmaceuticals, Venture Capital, Personnel Spruce Biosciences, congenital adrenal hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2017 Category: Pharmaceuticals Source Type: news

PwC: Arizona startups raise more than $40 million this quarter
Arizona companies received $40.6 million in venture capital investments during the third quarter of 2017 from six investments, according to the latest MoneyTree Report from PricewaterhouseCoopers LLP and CB Insights. This number is down from the $51.8 million received in the second quarter of the year from 12 investments, and down from the $71 million received in the first quarter from 10 investments, according to the report. The latest quarter is up from last year’s third quarter of $31.2 million… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2017 Category: Pharmaceuticals Authors: Hayley Ringle Source Type: news

PwC: Arizona startups raise more than $40 million this quarter
Arizona companies received $40.6 million in venture capital investments during the third quarter of 2017 from six investments, according to the latest MoneyTree Report from PricewaterhouseCoopers LLP and CB Insights. This number is down from the $51.8 million received in the second quarter of the year from 12 investments, and down from the $71 million received in the first quarter from 10 investments, according to the report. The latest quarter is up from last year’s third quarter of $31.2 million… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 12, 2017 Category: Biotechnology Authors: Hayley Ringle Source Type: news

This Tampa deal tops all Florida venture capital investments in the third quarter
Venture capital is a lead indicator of where jobs are coming from and a signal as to where the economy may be headed. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 10, 2017 Category: American Health Authors: Margie Manning Source Type: news

This Louisville startup was named the state's most valuable
Louisville biopharmaceutical startup Apellis Pharmaceuticals Inc. was named Kentucky's most valuable venture-backed startup by Seattle-based data and research company, PitchBook. Crestwood-based Apellis has raised $285 million in venture-backed funding since its inception, according to PitchBook's research, which ranked the top venture-capital-backed startup in each state. Apellis has raised more capital than any of the startups in Kentucky's surrounding states. The next highest was Franklin, Tenn.-based… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 9, 2017 Category: Pharmaceuticals Authors: Bridgett Weaver Source Type: news

Sight Sciences Secures $10MM in Oversubscribed Series C Financing
Ophthalmic Industry Veteran Shawn O'Neil Joins as Senior Vice President of Sales and Marketing MENLO PARK, Calif., Oct. 9, 2017 -- (Healthcare Sales & Marketing Network) -- Sight Sciences, Inc., a venture-backed, commercial stage ophthalmic medical dev... Devices, Ophthalmology, Venture Capital, Personnel Sight Sciences, VISCO360, TRAB360, Viscosurgical System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 9, 2017 Category: Pharmaceuticals Source Type: news

Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
TAMPA, Fla., Oct. 6, 2017 -- (Healthcare Sales & Marketing Network) -- Intezyne Technologies, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it closed an oversubscribed $10M Series A Preferred round lead ... Biopharmaceuticals, Oncology, Venture Capital, Personnel Intezyne Technologies, Cancer Resistance Pathway (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2017 Category: Pharmaceuticals Source Type: news

Vestagen Closes $9.5 Million Financing to Advance Adoption of Its VESTEX(R) Active Barrier Healthcare Uniforms
New Investors in the Financing Include VESTEX Customers ORLANDO, Fla., Oct. 5, 2017 -- (Healthcare Sales & Marketing Network) -- Vestagen Protective Technologies, Inc., which develops and markets VESTEX® Active Barrier1 fabric healthcare uniforms, ... Devices, Venture Capital Vestagen Protective Technologies, VESTEX, Active Barrier (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2017 Category: Pharmaceuticals Source Type: news

Too Little, Too Late
There is too little funding for early-stage technologies in the medical technology industry. Investors aren’t showing up for medtech opportunities, in part because of the time, capital, and uncertainty associated with reaching meaningful milestones, clearing regulatory hurdles, and securing reimbursement. This isn’t news, but a recent report raises an alarm, noting that a shortage of investments in the early phases of a new technology means patients are potentially losing out on lifesaving inventions. Recognizing this dearth of funding, Deloitte and AdvaMed conducted research with more than 20 leaders in the me...
Source: MDDI - October 4, 2017 Category: Medical Devices Authors: Marie Thibault Tags: Medical Device Business Source Type: news

Level Ex takes in $11M for mobile physician training games
Chicago-based Level Ex announced today that it has received $11 million in first round funding. The financing was led by 4490 Ventures, with additional participation from JAZZ Venture Partners, Pritzker Group Venture Capital, and other unnamed investors. (Source: mobihealthnews)
Source: mobihealthnews - October 3, 2017 Category: Information Technology Source Type: news

Rancho Cordova-based pharmaceutical company faces false-advertising lawsuit
After raising $10 million in venture capital in recent weeks, Nivagen is fending off a lawsuit that accuses the company of unfair competition. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 29, 2017 Category: American Health Authors: Scott Rodd Source Type: news

Rancho Cordova-based pharmaceutical company faces false-advertising lawsuit
After raising $10 million in venture capital in recent weeks, Nivagen is fending off a lawsuit that accuses the company of unfair competition. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 29, 2017 Category: Biotechnology Authors: Scott Rodd Source Type: news

KKR puts another $35m into Signostics parent company EchoNous
Private equity giant KKR (NYSE:KKR) put another $235 million into EchoNous, the parent company of Signostics, for the second time in as many years. The cash is earmarked for commercializing the Uscan ultrasound device, developing a vein-location device and an unnamed artificial intelligence-driven ultrasound project to market, Seattle-based EchoNous said. KKR put $35 million into the company back in November 2015. “KKR has been a strong partner since our first investment round together, so we are very pleased to receive additional support from them as we build a world-class company dedicated to solving ever...
Source: Mass Device - September 29, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Imaging Urology Wall Street Beat echonous Kohlberg Kravis Roberts & Co. L.P. Signostics Venture Capital/Private Equity Source Type: news

Leerink fund raises $313m for HIT plays
A fund backed by investment bank Leerink Partners raised $313 million for investments in the health information technology sector. Boston-based Leerink Transformation Partners said its first fund was significantly oversubscribed compared with the $250 million it initially sought to raise. Co-founder Todd Cozzens is a medical device industry veteran and former Sequoia Capital partner; Dr. Jared Kesselheim, a internist, spent 8 years at Bain Capital Ventures. “We are distinctly positioned to help the best healthcare IT and services companies and their leaders accelerate their growth because of our differentiated b...
Source: Mass Device - September 29, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Health Information Technology Wall Street Beat Leerink Partners Venture Capital/Private Equity Source Type: news

Ellen Pao Has Some Sage Advice for Dealing With Sexism
Ellen Pao made history when she sued her employer, the powerful Silicon Valley venture capital firm Kleiner Perkins, for discrimination in 2015. She accused the firm of blocking women and people of color from meetings, email discussions and networking events, and of cultivating a boys-club culture in the office, filled with racist and sexist language. She lost the case but broke open a conversation about the pernicious problems of sexism and racism in the tech industry. Pao went on to become the CEO of Reddit, where she banned revenge porn and harassment. Since leaving Reddit, Pao has gone on to found Project Include with ...
Source: TIME.com: Top Science and Health Stories - September 28, 2017 Category: Consumer Health News Authors: Eliana Dockterman Tags: Uncategorized sexism sexism in tech Silicon Valley Source Type: news

Abiomed joins $15m round for acute heart failure treatment dev Magenta Medical
Novel acute heart failure treatment developer Magenta Medical said it closed a $15 million Series B round of financing, joined by transcatheter heart pump dev Abiomed (NSDQ:ABMD). Investors in the Israel-based company included Pitango Venture capital, JAFCO and a group of industry investors led by Dr. Jacques Seguin, who founded CoreValve. Dr. Seguin will also join the company’s board of directors as part of the funding round. Magenta Medical was founded in 2012 and is developing “novel therapeutic approaches to the management and treatment of acute heart failure.” The treatment is based around ...
Source: Mass Device - September 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Catheters Abiomed magentamedical Source Type: news

With Venture Capital In Digital Health Sloshing Around, Startups Should Choose Investors Carefully
Health Catalyst Capital is only one of a handful of health IT-focused VC firms with healthcare companies as investors that help inform investments. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 28, 2017 Category: Pharmaceuticals Authors: Zina Moukheiber, Contributor Source Type: news

Magenta Medical, Developer of Novel Heart Failure Therapies, Secures $15 Million in Series B Financing
Round led by Abiomed Inc. and Pitango Venture Capital, joined by JAFCO and a group of private investors led by Prof. Jacques Seguin; Dr. David Israeli appointed CEO TEL-AVIV, Israel, September 28, 2017 -- (Healthcare Sales & Marketing Network) -- Magen... Devices, Interventional, Cardiology, Venture Capital Magenta Medical, heart failure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2017 Category: Pharmaceuticals Source Type: news

Abiomed invests in Israeli medical device maker Magenta
JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc, a maker of catheter-based heart pumps, and venture capital firm Pitango. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

SA biotech headed west to try and score potential clients and cash
StemBioSys Inc. is one of a few dozen companies that's been selected to present at an international conference in California expected to attract hundreds of biomedical industry companies, bankers and venture capital firms. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 27, 2017 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

CleanSlate addiction centers ink Humana network deal, plan second area clinic
CleanSlate Centers, a fast-growing, venture capital-funded chain of addiction-treatment centers that expanded to metro Milwaukee in July, received a boost with news that it was added to the Humana health insurance network and confirmed that a second Milwaukee-area location will open in Waukesha. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - September 27, 2017 Category: Health Management Authors: Rich Kirchen Source Type: news

McKesson Ventures Expands Investment Team
SAN FRANCISCO – September 27, 2017 – McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that Carrie Hurwitz Williams will join as Principal, and Irem Mertol as Director. Williams will play a key role in promoting McKesson Ventures as a strategic investment partner fo... (Source: McKesson News)
Source: McKesson News - September 27, 2017 Category: Information Technology Source Type: news

DiscGenics Raises $14 Million in Series B Financing
SALT LAKE CITY, Sept. 26, 2017 -- (Healthcare Sales & Marketing Network) -- DiscGenics, Inc., a clinical stage regenerative medicine company focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerativ... Regenerative Medicine, Orthopaedic, Venture Capital DiscGenics, cell therapy, degenerative disc disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 26, 2017 Category: Pharmaceuticals Source Type: news

Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
French biotech company has produced the first biotherapeutic nanobots to engineer the microbiome. PARIS, Sept. 26, 2017 -- (Healthcare Sales & Marketing Network) -- Eligo Bioscience, the French microbiome company developing drugs to prevent and treat b... Biopharmaceuticals, Venture Capital Eligo Bioscience, microbiome, biotherapeutic nanobots (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 26, 2017 Category: Pharmaceuticals Source Type: news

How Artificial Intelligence Could Save Healthcare
They say the only two certainties in life are death and taxes, but you could also make an argument for adding rising healthcare costs to the list. “There is no end in sight to the amount of healthcare spending because it scales with multiple on the population,” Josh Makower, MD, general partner venture capital firm New Enterprise Associates (one of the top 10 medtech VC firms), told an audience at the Medtech Conference in San Jose yesterday. Speaking on a panel about the future of healthcare delivery at the event hosted by medtech industry trade group AdvaMed, Makower went on to assert that medical devices and...
Source: MDDI - September 26, 2017 Category: Medical Devices Authors: Jamie Hartford Tags: Medical Device Business Source Type: news

Lightstone Ventures raises $250m second fund
Lightstone Ventures this week said it raised $250 million for its second fund, $50 million more than it was aiming for. Menlo Park, Calif.- and Boston-based Lightstone said it plans to use the cash to back “companies developing therapies which have the potential to change the practice of medicine” and to found companies via its alliance with the Foundry medtech incubator and other strategic partners. The second fund has already made an investment, joining the $30 million Series A round for pharma startup Disarm Therapeutics. “The successful implementation of our strategy requires the ability to ident...
Source: Mass Device - September 22, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat Lightstone Ventures Venture Capital/Private Equity Source Type: news

Metavention CEO hops to another VC-backed startup
Kevin Hykes has left his post as CEO of Metavention to take over as top executive at another venture capital backed startup that is now exploring opening a Twin Cities office. Hykes has been named CEO of Relievant Medsystems, a Sunnyvale, Calif.-based company that aims to treat lower back pain by destroying nerves. He was previously CEO of Metavention, whose headquarters moved from California to Eden Prairie under Hykes' leadership. Metavention develops technology to tr eat diabetes. Asked whether… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 21, 2017 Category: American Health Authors: Katharine Grayson Source Type: news